ICON and DIA Amplify Thought Leadership and Debate with DIA Live 2017
16 Juin 2017 - 11:00AM
Business Wire
Social media aggregation site will highlight
real-time digital conversations at DIA 2017
ICON plc, (NASDAQ: ICLR) a global provider of drug
development solutions and services to the pharmaceutical,
biotechnology and medical device industries, today announced that
for the second consecutive year it will present DIA Live – a social
media aggregation site that allows visitors to track and analyse
Twitter conversations from delegates at the DIA 2017 Annual Meeting
(18 - 22 June, Chicago, IL).
DIA is the largest global interdisciplinary gathering of life
sciences professionals, with over 7,000 visitors from over 50
countries. DIA Live will provide a single source for visitors to
view the social media conversations from conference participants,
alongside broader conversations from Twitter users around the world
using the hashtag #DIA2017. DIA Live will launch on the 17June and
will aggregate and stream a live feed of tweets sent by conference
delegates as well as other industry participants.
DIA Live features include:
- Real-time view of trending topics,
breaking news stories and expert commentary from the
conference
- Filtering, by keyword, hashtag, content
format or Twitter profile to enable easy personalisation of
content
- Ability for visitors to create and
publish stories and to engage with the most influential experts in
the industry
- For bloggers and media publications,
the ability to create and customise widgets that can be easily
embedded in other websites, providing a real-time stream of content
and infographics from DIA Live
- An interactive timeline that presents
activity volumes, key highlights and the ability to review
conversations from prior days as the conference progresses
This is the second time that ICON and DIA have collaborated to
present DIA Live. In 2016 the platform analysed over 4.5K tweets
from conference delegates discussing a variety of industry topics,
ranging from big data and cyber security to patient engagement and
health care regulation.
David Green, VP Marketing, ICON said “Following the success of
DIA Live 2016, we are delighted to continue our collaboration with
DIA to help industry professionals join the conversation on a
variety of important topics, including disruptive innovation,
special patient populations, translational science and value and
market access. DIA Live combines powerful data analysis and
visualisation features to provide a unique digital forum to connect
the world’s largest gathering of life sciences professionals.”
“DIA Live will provide valuable insight and analysis into the
conversations taking place at DIA 2017 Global Annual Meeting while
enabling individuals from around the world to engage and
participate in the discussions covering the most pressing issues
facing the life sciences industry today,” said Sudip Parikh SVP and
Managing Director, DIA Americas. “This DIA Live social media
aggregation site offers a digital window into the world’s largest
gathering of life science industry professionals highlighting
digital conversation hotspots and helping to amplify thought
leadership and debate at DIA 2017. If you’re onsite at this year’s
event it will add to your experience and if you're not, it's the
second best thing.”
To join the 2017 DIA conversation, follow and engage with our
team via www.dialive.org
About DIA 2017
DIA 2017 is DIA’s global annual meeting to advance health care
product development around the world by connecting stakeholders to
interdisciplinary insights and innovation. As the organization’s
largest interdisciplinary event, DIA 2017 is a gathering of global
perspectives bringing together a network of more than 7,000
professionals to foster innovation that leads to the development of
safe and effective products and therapies to patients. The global
annual meeting will draw attendees from 51 countries for the
five-day conference, which also features a three-day expo with more
than 450 exhibitors. For more information visit
http://www.diaglobal.org/Flagship/DIA-2017 or follow DIA on
Twitter, LinkedIn, and Facebook. Join the conversation using
#DIA2017
About ICON plc
ICON plc is a global provider of drug development solutions and
services to the pharmaceutical, biotechnology and medical device
industries. The company specialises in the strategic development,
management and analysis of programs that support clinical
development - from compound selection to Phase I-IV clinical
studies. With headquarters in Dublin, Ireland, ICON currently,
operates from 87 locations in 38 countries and has approximately
12,300 employees.
Further information is available at www.iconplc.com
ICON/ICLR-G
This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and
industry conditions. These statements are not guarantees of future
performance or actual results, and actual results, developments and
business decisions may differ from those stated in this press
release. The forward-looking statements are subject to future
events, risks, uncertainties and other factors that could cause
actual results to differ materially from those projected in the
statements, including, but not limited to, the ability to enter
into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the
integration of new business mergers and acquisitions, as well as
economic and global market conditions and other risks and
uncertainties detailed from time to time in SEC reports filed by
ICON, all of which are difficult to predict and some of which are
beyond our control. For these reasons, you should not place undue
reliance on these forward-looking statements when making investment
decisions. The word "expected" and variations of such words and
similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they
are made and we do not undertake any obligation to update publicly
any forward-looking statement, either as a result of new
information, future events or otherwise. More information about the
risks and uncertainties relating to these forward-looking
statements may be found in SEC reports filed by ICON, including its
Form 20-F, F-1, S-8 and F-3, which are available on the SEC's
website at http://www.sec.gov.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170616005181/en/
ICON Media ContactCamille FrederixWeber Shandwick+44 (0)
207 067 0272cfrederix@webershandwick.com
ICON (NASDAQ:ICLR)
Graphique Historique de l'Action
De Juil 2024 à Août 2024
ICON (NASDAQ:ICLR)
Graphique Historique de l'Action
De Août 2023 à Août 2024